The 13D Report
The 13D Report
Shareholder activism
⌘K
Signup free
activistletters

Silver Star (SLVS) Shareholders Warned: Hartman Urges “Vote BLUE” to Counter Board’s Proxy Tactics

Summary

The Hartman Shareholder Alliance warns shareholders not to be misled by Silver Star’s Board, accusing it of spreading false claims to invalidate BLUE votes. They clarify that voting BLUE ensures shareholder voices are counted and urge investors not to “revote” WHITE, as it would cancel their prior BLUE vote. The letter denounces the Board’s tactics as deceptive and calls on shareholders to vote BLUE to protect their investment and demand change.

DO NOT PANIC VOTE – Your Vote Is Secure

July 16, 2025

Dear Shareholders,

You may have received a letter from the Silver Star Board filled with fearmongering and misinformation. Let’s set the record straight.

The current Board is trying to distract you from the real issues. Instead of addressing their failures, they are attacking Al Hartman and deliberately trying to confuse shareholders.

Here’s the truth:

· Hartman is NOT trying to block a quorum or “win by default.” That’s a false narrative to scare you. Voting BLUE simply ensures your shares are counted and your voice is heard.
· They are trying to trick you into canceling your BLUE vote. They know the last vote cast is the only one that counts. By pressuring you to “revote” WHITE, they can erase your support for change.

✅ THE LAST VOTE COUNTS. If you have already voted on the BLUE card, do NOT vote on the WHITE Silver Star proxy card. Voting WHITE now will void your BLUE vote.

✅ If you haven’t voted yet, vote BLUE today to protect your investment.

The current Board wants to stay in power at any cost, even if it means misleading you. Don’t let their tactics steal your voice or your future.

Thank you for your trust and support as we work to restore value and integrity.

See the attached proxy letter for more details. Click here to read the full letter.

If you have not voted, call us directly at (619) 664-4780 to vote for the return of your capital or vote the blue proxy from our online e-mail.

If you have any questions, contact us at IR@hartman-investments.com.

Thank you for standing with us.

Sincerely,

Al Hartman

The Hartman Shareholder Alliance Team

Source:

https://www.sec.gov/Archives/edgar/data/831616/000110465925069962/tm2521557d1_dfan14a.htm

Member discussion

More like this

STAAR Surgical (STAA): Broadwood Partners Urges Shareholders to Reject Alcon Merger Over Governance and Valuation Concerns

Summary Broadwood Partners’ presentation argues that STAAR Surgical’s sale to Alcon is ill-timed, flawed, and undervalued. It claims STAAR’

Khrom Capital Pushes Acadia Healthcare (ACHC) Board to Pursue Sale, Slams Entrenched Leadership and Poor Capital Allocation

Summary Khrom Capital, owning 5.5% of Acadia Healthcare, criticized the company’s decade-long underperformance, poor capital allocation, and entrenched

STAAR Surgical (STAA): Broadwood Capital Urges Shareholders to Reject Alcon Merger, Highlighting Governance Conflicts and Poor Timing

Summary Broadwood Capital, owning 27.5% of STAAR Surgical, urged shareholders to vote against the proposed $28-per-share sale to Alcon,

Al Hartman Presses Silver Star Properties REIT (SLVS) Holders: Reject Current Board, Back Liquidation Plan Amid Alleged Misconduct and Value Destruction

Summary Al Hartman’s Hartman Shareholder Alliance urges Silver Star investors to vote the BLUE proxy as a “last chance”

Broadwood Partners Challenges STAAR Surgical (STAA) Sale to Alcon, Citing Inopportune Timing, Governance Issues, and Undervaluation

Summary Broadwood Partners, STAAR Surgical’s largest shareholder with a 27.5% stake, urged stockholders to vote against the proposed

Yunqi Capital Challenges STAAR Surgical (STAA)–Alcon Deal, Citing Undervaluation, Weak China Outlook Assumptions, and Governance Failures

Summary Yunqi Capital, a 5.1% shareholder of STAAR Surgical, announced it will vote against the company’s proposed $28